Kevin Caliendo
Stock Analyst at UBS
(4.21)
# 1,546
Out of 5,128 analysts
428
Total ratings
56.3%
Success rate
6.5%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAH Cardinal Health | Reiterated: Buy | $295 → $310 | $277.45 | +11.73% | 25 | Nov 6, 2026 | |
| CERT Certara | Reiterated: Hold | $10 → $13 | $11.73 | +10.83% | 2 | Nov 6, 2026 | |
| SDGR Schrödinger | Reiterated: Hold | $21 → $30 | $31.52 | -4.82% | 3 | Nov 6, 2026 | |
| CRL Charles River Laboratories International | Rated: Buy | $357 → $387 | $342.69 | +12.93% | 2 | Nov 5, 2026 | |
| CVS CVS Health | Rated: Buy | $118 → $107 | $89.52 | +19.53% | 37 | Nov 5, 2026 | |
| MCK McKesson | Rated: Buy | $1,200 → $1,250 | $1,079.79 | +15.76% | 35 | Nov 5, 2026 | |
| MDLN Medline | Rated: Buy | $43 → $49 | $42.16 | +16.22% | 5 | Nov 5, 2026 | |
| NVST Envista Holdings | Rated: Hold | $27 → $29 | $25.32 | +14.53% | 7 | Nov 5, 2026 | |
| AHCO AdaptHealth | Reiterated: Buy | $10 → $9 | $7.80 | +15.38% | 20 | Nov 4, 2026 | |
| HSIC Henry Schein | Reiterated: Hold | $94 → $95 | $88.42 | +7.44% | 12 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $6 → $9 | $8.94 | +0.67% | 17 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $195 → $236 | $199.70 | +18.18% | 3 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $380 → $420 | $372.23 | +12.83% | 24 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $345 | $274.53 | +25.67% | 3 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $673 → $700 | $664.77 | +5.30% | 2 | Oct 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $22 → $24 | $20.38 | +17.76% | 2 | Oct 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $245 → $250 | $258.69 | -3.36% | 21 | Oct 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $430 → $400 | $349.88 | +14.32% | 28 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $1.5 | $0.1452 | +933.06% | 20 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $3.75 | $3.65 | +2.74% | 9 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $33 | $28.84 | +14.42% | 3 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $186 → $189 | $172.08 | +9.83% | 26 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $4.99 | +0.20% | 8 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $13 | $14.37 | -9.53% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $17 | $9.76 | +74.18% | 20 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $82 → $78 | $88.62 | -11.98% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $390 → $375 | $301.45 | +24.40% | 11 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $18 | $7.69 | n/a | 13 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $374 → $180 | $209.25 | n/a | 7 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $9 | $12.31 | n/a | 9 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $250 → $285 | $446.31 | n/a | 12 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $72 → $79 | $70.48 | n/a | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $520 → $640 | $402.94 | n/a | 10 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $595 → $610 | $429.48 | n/a | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $180 → $175 | $280.41 | n/a | 4 | Oct 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $15.86 | n/a | 1 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $8 | $4.75 | n/a | 2 | Mar 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $118.37 | n/a | 1 | Jan 30, 2018 |
Cardinal Health
Nov 6, 2026
Reiterated: Buy
Price Target: $295 → $310
Current: $277.45
Upside: +11.73%
Certara
Nov 6, 2026
Reiterated: Hold
Price Target: $10 → $13
Current: $11.73
Upside: +10.83%
Schrödinger
Nov 6, 2026
Reiterated: Hold
Price Target: $21 → $30
Current: $31.52
Upside: -4.82%
Charles River Laboratories International
Nov 5, 2026
Rated: Buy
Price Target: $357 → $387
Current: $342.69
Upside: +12.93%
CVS Health
Nov 5, 2026
Rated: Buy
Price Target: $118 → $107
Current: $89.52
Upside: +19.53%
McKesson
Nov 5, 2026
Rated: Buy
Price Target: $1,200 → $1,250
Current: $1,079.79
Upside: +15.76%
Medline
Nov 5, 2026
Rated: Buy
Price Target: $43 → $49
Current: $42.16
Upside: +16.22%
Envista Holdings
Nov 5, 2026
Rated: Hold
Price Target: $27 → $29
Current: $25.32
Upside: +14.53%
AdaptHealth
Nov 4, 2026
Reiterated: Buy
Price Target: $10 → $9
Current: $7.80
Upside: +15.38%
Henry Schein
Nov 4, 2026
Reiterated: Hold
Price Target: $94 → $95
Current: $88.42
Upside: +7.44%
Nov 2, 2026
Rated: Hold
Price Target: $6 → $9
Current: $8.94
Upside: +0.67%
Oct 29, 2026
Rated: Hold
Price Target: $195 → $236
Current: $199.70
Upside: +18.18%
Oct 29, 2026
Rated: Buy
Price Target: $380 → $420
Current: $372.23
Upside: +12.83%
Oct 28, 2026
Reiterated: Buy
Price Target: $345
Current: $274.53
Upside: +25.67%
Oct 23, 2026
Rated: Hold
Price Target: $673 → $700
Current: $664.77
Upside: +5.30%
Oct 20, 2026
Rated: Hold
Price Target: $22 → $24
Current: $20.38
Upside: +17.76%
Oct 19, 2026
Rated: Hold
Price Target: $245 → $250
Current: $258.69
Upside: -3.36%
Oct 16, 2026
Reiterated: Buy
Price Target: $430 → $400
Current: $349.88
Upside: +14.32%
Aug 13, 2026
Reiterated: Hold
Price Target: $4.5 → $1.5
Current: $0.1452
Upside: +933.06%
Aug 13, 2026
Reiterated: Hold
Price Target: $2 → $3.75
Current: $3.65
Upside: +2.74%
Jul 30, 2026
Reiterated: Buy
Price Target: $37 → $33
Current: $28.84
Upside: +14.42%
Jul 23, 2026
Reiterated: Hold
Price Target: $186 → $189
Current: $172.08
Upside: +9.83%
May 8, 2026
Reiterated: Buy
Price Target: $5
Current: $4.99
Upside: +0.20%
May 8, 2026
Reiterated: Buy
Price Target: $12 → $13
Current: $14.37
Upside: -9.53%
May 7, 2026
Reiterated: Buy
Price Target: $18 → $17
Current: $9.76
Upside: +74.18%
May 6, 2026
Reiterated: Hold
Price Target: $82 → $78
Current: $88.62
Upside: -11.98%
Feb 9, 2026
Reiterated: Buy
Price Target: $390 → $375
Current: $301.45
Upside: +24.40%
Oct 31, 2025
Reiterated: Hold
Price Target: $17 → $18
Current: $7.69
Upside: n/a
Jul 25, 2025
Reiterated: Hold
Price Target: $374 → $180
Current: $209.25
Upside: n/a
May 8, 2025
Reiterated: Hold
Price Target: $12 → $9
Current: $12.31
Upside: n/a
Feb 24, 2025
Reiterated: Hold
Price Target: $250 → $285
Current: $446.31
Upside: n/a
Dec 21, 2023
Reiterated: Hold
Price Target: $72 → $79
Current: $70.48
Upside: n/a
Oct 16, 2023
Upgraded: Buy
Price Target: $520 → $640
Current: $402.94
Upside: n/a
Oct 24, 2022
Reiterated: Buy
Price Target: $595 → $610
Current: $429.48
Upside: n/a
Oct 3, 2022
Reiterated: Hold
Price Target: $180 → $175
Current: $280.41
Upside: n/a
Mar 9, 2022
Upgraded: Buy
Price Target: n/a
Current: $15.86
Upside: n/a
Mar 3, 2020
Reiterated: Hold
Price Target: $12 → $8
Current: $4.75
Upside: n/a
Jan 30, 2018
Upgraded: Buy
Price Target: n/a
Current: $118.37
Upside: n/a